The stock was priced at $28 per share, for a total of $700,000 transaction. Mr. Lavigne now owns around 983,000 shares of the company’s stock valued around $27.5 million. Stock price opened at $37.14 on Aug. 27 with a market cap of $354.5 million.
The company’s 52-week high is $53.51 and low is $34.95. LDR COO James Burrows sold around 19,000 shares on the open market earlier in August, after Piper Jaffray analysts raised their price from $38 to $40 per share and giving the company an “overweight” rating.
Meanwhile, RBC Capital initiated LDR coverage in June with an “outperform” rating and $34 target price.
More articles on orthopedic devices:
Amedica names Dr. B. Sonny Bal chairman of the board
8 predictions on the advanced orthopedic technologies market through 2019
French surgeon performs first spine surgery using Expanding Orthopedics’ FLXfit
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
